Occult breast cancer: Scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer

Radiology

Volumn 237, Issue 1, 2005, Pages 274-280

  Brem, Rachel F ^a   Rapelyea, Jocelyn A ^a   Zisman, Gilat ^a   Mohtashemi, Kevin ^a   Raub, Joyce ^a   Teal, Christine B ^a   Majewski, Stan ^b   Welch, Benjamin L ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON NATIONAL ACCELERATOR FACILITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; DIAGNOSTIC ACCURACY; ECHOMAMMOGRAPHY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOISOTOPE DISTRIBUTION; SCINTILLATION CAMERA; SCINTIMAMMOGRAPHY; STATISTICAL ANALYSIS;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; GAMMA CAMERAS; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI;

EID: 25144433342     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2371040758     Document Type: Article

References (34)

1. Sickles EA. Mammographic features of early breast cancer. AJR Am J Roentgenol 1984;143:461-464.
2. Niloff PH, Sheiner NM. False-negative mammograms in patients with breast cancer. Can J Surg 1981;24:50-52.
3. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002; 225(1):165-175.
4. Khalkhali I, Mena I, Jouanne E. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994;178:491-497.
5. Khalkhali I, Cutrone JA, Mena I. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995;196:421-426.
6. Brem RF, Schoonjans JM, Kieper DA, Majewski S. High-resolution scintimammography: a pilot study. J Nucl Med 2002;43:909-915.
7. Khalkhali I, Villanueva-Meyer J, Edell S. Diagnostic accuracy of Tc-99m sestamibi breast imaging: multi-center trial results. J Nucl Med 2000;41(12):1973-1979.
8. Burak Z, Argon M, Memis A. Evaluation of palpable breast masses with Tc-99m-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994;15:604-612.
9. Helbich TH, Becherer A, Trattnig S. Differentiation of benign and malignant breast lesions: MR Imaging versus Tc-99m sestamibi scintimammography. Radiology 1997; 202:421-429.
10. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. Technetium 99-m MIBI scintimammography in palpable and nonpalpable breast lesions. J Nucl Med 1998; 39:86-91.
11. Taillefer R, Robidoux A, Lambert R. Technetium 99-m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
12. Clifford EJ, Lugo-Zamudio C. Scintimammography in the diagnosis of breast cancer. Am J Surg 1996;172:483-486.
13. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21: 432-436.
14. Palmedo H, Biersak HJ, Lastoria S. Scintimammography with technitium-99m methoxyisobutylisonitrile: results of a prospective European multi-center trial. Eur J Nucl Med 1998;25:375-385.
15. Tiling R, Khalkhali I, Sommer H. The role of Tc-99m sestamibi scintimammography and contrast enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms. Eur J Nucl Med 1997;24:1221-1229.
16. Home T, Pappo I, Cohenpour M. Tc-99m MIBI scintimammography for the detection of breast malignancies: the contribution of the count ratio to specificity. Nucl Med Commun 1999;20:511-516.
17. Arslan N, Ozturk E, Ilgan S. Tc-99m MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis. Nucl Med Commun 1999;20:317-325.
18. Maffioli L, Agresti R, Chiti A, Crippa F. Prone scintimammography in patients with nonpalpable breast lesions. Anticancer Res 1996;16:1269-1274.
19. Scopinaro F, Ierardi M, Porfiri LM, et al. Tc-99m MIBI prone scintimammography in patients with high and intermediate risk mammography. Anticancer Res 1997; 17:1635-1638.
20. Scopinaro F, Schillaci O, Ussof W, et al. A three center trial on the diagnostic accuracy of Tc-99m MIBI scintimammography. Anticancer Res 1997;17:1631-1634.
21. Tolmos J, Cutrone JA, Wang B. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography. J Natl Cancer Inst 1998;90:846-849.
22. Palmedo H, Grunwald F, Bender H. Scintimammography with technetium-99m methoxyisobutylionitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 1996;23:940-946.
23. Majewski S, Kieper D, Keppel C. Optimization of dedicated scintimammography procedure using small detector prototypes and compressible breast phantoms (abstr). Presented at the IEEE Medical Imaging Conference, Lyon, France, October 2000.
24. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353(9169):1993-2000.
25. Schoonjans JM, Brem RF. Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses. J Ultrasound Med 2001;20(9):967-972.
26. Waxman AD. The role of (99m)Tc methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med 1997;27:40-54.
27. Cutrone JA, Khalkhali I, Yosper LS. Tc-99m sestamibi scintimammography for the evaluation of breast masses in patients with radiographically dense breasts. Breast J 1999;5:383-388.
28. Gupta P, Waxman A, Nguyen K. Correlation of Tc-99m sestamibi uptake with histopathologic characteristics in patients with benign breast disease (abstr). J Nucl Med 1996;37:250.
29. Cotran S, Lester S. The female breast. Pathologic basis of disease. 6th ed. Philadelphia, Pa: Saunders, 1999; 1100-1102.
30. Rice SJ, Khalkhali I, Diggles L. The role of radionuclide imaging in the evaluation of suspected breast abnormalities. Breast Dis 1998;10:177-187.
31. Taillefer R. Clinical applications of 99mTc-sestamibi scintimammography. Semin Nucl Med 2005;35:100-115.
32. Klaus AJ, Klingensmith WC 3rd, Parker SH, Stavros AT, Sutherland JD, Aldrete KD. Comparative value of Tc-99m sestamibi scintimammography and sonography in the diagnostic workup of breast masses. AJR Am J Roentgenol 2000;174:1779-1783.
33. Williams MB, Pisano ED, Schnall MD, Fajardo LL. Future directions in imaging of breast disease. Radiology 1998;206:297-300.
34. Kuhl CK, Mielcarek P, Klaschik S. Dynamic breast MR imaging: are the signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110.